TransCode Therapeutics Inc. Made Headway

Wed, Dec 07, 2022 at 07:00 PM
TransCode Therapeutics Inc. Made Headway

TransCode Therapeutics Inc. (RNAZ:NASDAQ) rocketted at $0.98, a gain of 133.4%. On Wed, Dec 07, 2022, RNAZ:NASDAQ hit a New 2-Week High of $0.98. The stock got featured on our News Catalysts scanner on Wed, Dec 07, 2022 at 05:27 PM in the 'BIOTECH' category. From Wed, Nov 23, 2022, the stock recorded 33.33% Up Days and 30.00% Green Days

The stock spiked on Wed, Oct 26, 2022 at $1.55 with a volume of 34M+.

About TransCode Therapeutics Inc. (RNAZ:NASDAQ)

TransCode Therapeutics Inc is an RNA oncology company. It is created to defeat the cancer through the intelligent design and effective delivery of RNA therapeutics.

Share
Get 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
monthly
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.